Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9789.
-
eHealth Q3 2026 Earnings Call TranscripteHealth (NASDAQ:EHTH) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
-
Western Union Q3 2026 Earnings Call TranscriptWestern Union (NYSE:WU) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs.
-
Energy Recovery Q3 2026 Earnings Call TranscriptEnergy Recovery (NASDAQ:ERII) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
-
National Vision Q3 Results Set to Focus on Traffic, UBS SaysAnalysts at UBS have indicated that upcoming third-quarter results for National Vision Holdings, Inc. will likely center on store traffic trends.
-
Arko Petroleum Q3 2026 Earnings Call TranscriptArko Petroleum (NASDAQ:APC) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
-
Civeo Insider Executes Share SaleA Civeo Corporation insider has sold company shares valued at $865,615, according to a recent SEC filing.
-
Analyst Actions Following Vital Farms Q3 EarningsFollowing the company's third-quarter earnings report, analysts adjusted their ratings and price targets for Vital Farms, including an upgrade by Craig-Hallum and a price target reduction by Needham.
-
FACT II Acquisition Corp. Postpones Extraordinary General Meeting of ShareholdersFACT II Acquisition Corp. has announced the postponement of its scheduled Extraordinary General Meeting of Shareholders.
-
Wolfspeed, Inc. Reports Fiscal Q1 2027 Financial ResultsWolfspeed, Inc. announced its fiscal first-quarter 2027 financial results, reporting revenue of $155.0 million and an adjusted loss of $2.03 per share.
-
UBS Adjusts Price Target on AdaptHealthUBS lowered its price target on AdaptHealth shares from $10 to $9 while maintaining a Buy rating.
-
Analyst Adjusts Price Target for NAPCO Security TechnologiesAn analyst firm lowered the price target for NAPCO Security Technologies to $43.00 from $49.00.
-
Keefe, Bruyette & Woods Adjusts Price Target for MVB FinancialKeefe, Bruyette & Woods has lowered its price target for MVB Financial Corp. to $31.00 per share from $34.00.
-
L.B. Foster Raises Fiscal 2026 Sales OutlookFollowing strong third-quarter results, L.B. Foster Company increased its full-year 2026 sales guidance to a range of $570 million to $590 million.
-
agilon health, inc. Reports Third Quarter 2026 Financial Resultsagilon health, inc. announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $1.52 billion.
-
Waterstone Financial, Inc. Third-Quarter Earnings ForecastWaterstone Financial, Inc. is projected to report third-quarter earnings per share of 32 cents, compared to 45 cents in the same period last year.
-
Cooper Standard Reports Third Quarter 2026 Financial ResultsCooper Standard announced its financial results for the third quarter of 2026, reporting sales of $708.6 million and net new business awards of $148.8 million.
-
Anthropic Expands AI for Science Credits ProgramAnthropic has expanded its AI for Science credits program to include major research funders and institutes, enabling broader access to its Claude models for scientific research.
-
Dexterra Group Inc. Reports Third Quarter 2026 Financial ResultsDexterra Group Inc. announced its financial results for the third quarter of 2026, reporting growth in consolidated revenue and adjusted EBITDA compared to the same period in 2025.
-
NexPoint Residential Trust Lowers Full-Year 2026 GuidanceNexPoint Residential Trust reduced its full-year Core FFO and same-store net operating income (NOI) outlook following third-quarter results.
-
Edwards Lifesciences Reports Third Quarter 2026 Financial ResultsEdwards Lifesciences announced its financial results for the third quarter ended September 30, 2026, reporting $1.72 billion in sales and adjusted earnings per share of $0.80.